Search Results - "Vogler, Sabine"

Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study by Vogler, Sabine, Dr, Vitry, Agnes, PhD, Babar, Zaheer-Ud-Din, PhD

“…Summary Background Cancer drugs challenge health-care systems because of their high prices. No cross-country price comparison of cancer drugs for a large…”
Get full text

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis by Iyengar, Swathi, Tay-Teo, Kiu, Vogler, Sabine, Beyer, Peter, Wiktor, Stefan, de Joncheere, Kees, Hill, Suzanne

“…New hepatitis C virus (HCV) medicines have markedly improved treatment efficacy and regimen tolerability. However, their high prices have limited access,…”
Get full text

Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure by Vogler, Sabine, Schneider, Peter, Zuba, Martin, Busse, Reinhard, Panteli, Dimitra

“…Introduction: Biosimilar medicines are considered promising alternatives to new biologicals with high price tags. The extent of savings resulting from…”
Get full text

Assessing, Pricing and Funding Point-of-Care Diagnostic Tests for Community-Acquired Acute Respiratory Tract Infections-Overview of Policies Applied in 17 European Countries by Vogler, Sabine, Windisch, Friederike

“…Point-of-care diagnostic tests for community-acquired acute respiratory tract infections (CA-ARTI) can support doctors by improving antibiotic prescribing…”
Get full text

Improving antibiotic prescribing – Recommendations for funding and pricing policies to enhance use of point-of-care tests by Vogler, Sabine, Steigenberger, Caroline, Windisch, Friederike

“…[Display omitted] •Diagnostics can address antimicrobial resistance by improving antibiotic prescribing.•Funding and pricing policies can enhance the uptake of…”
Get full text

Public spending on orphan medicines: a review of the literature by Gombocz, Margit, Vogler, Sabine

“…Little is known about how much public payers spend on orphan medicines. This study aimed at identifying information on orphan medicine expenditure incurred by…”
Get full text

Barriers and Facilitators in Pricing and Funding Policies of European Countries That Impact the Use of Point-of-Care Diagnostics for Acute Respiratory Tract Infections in Outpatient Practices by Steigenberger, Caroline, Windisch, Friederike, Vogler, Sabine

“…Antimicrobial resistance is a major global health threat, which is increased by the irrational use of antibiotics, for example, in the treatment of respiratory…”
Get full text

How large are the differences between originator and generic prices? Analysis of five molecules in 16 European countries by Sabine Vogler

“…OBJECTIVE: To survey the price differences between originators and generics for a selected basket of molecules and to analyze similarities and differences with…”
Get full text

Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation by Vogler, Sabine, Schneider, Peter, Lepuschütz, Lena

“…Abstract Background Several governments apply the policy of external price referencing (EPR), which considers the prices of a medicine in one or more other…”
Get full text

Medication wasted – Contents and costs of medicines ending up in household garbage by Vogler, Sabine, de Rooij, Roger H.P.F.

“…Despite potentially considerable implications for public health, the environment and public funds, medicine waste is an under-researched topic. This study aims…”
Get full text

Analysis of Medicine Prices in New Zealand and 16 European Countries by Vogler, Sabine, PhD, Kilpatrick, Kate, BPharm(Hons), Babar, Zaheer-Ud-Din, BPharm, MPharm(Clin Pharm), PhD

“…Abstract Objective To compare prices of medicines, both originators and generics, in New Zealand and 16 European countries. Methods Ex-factory price data as of…”
Get full text

Shortages of Medicines to Treat COVID-19 Symptoms during the First Wave and Fourth Wave: Analysis of Notifications Reported to Registers in Austria, Italy, and Spain by Sánchez, Diana Ivonne Rodríguez, Vogler, Sabine

“…The study aimed to investigate medicine shortages of critical relevance in the pandemic. A total of 487 active substances for the treatment of COVID-19-related…”
Get full text

Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan by Vogler, Sabine, Schneider, Peter, Dedet, Guillaume, Bak Pedersen, Hanne

“…Out-of-pocket (OOP) payments can constitute a major barrier for affordable and equitable access to essential medicines. Household surveys in Kyrgyzstan pointed…”
Get full text

Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines by Vogler, Sabine, Zimmermann, Nina, Haasis, Manuel Alexander, Knoll, Verena, Espin, Jaime, Mantel-Teeuwisse, Aukje K, Panteli, Dimitra, Suleman, Fatima, Wirtz, Veronika J, Babar, Zaheer-Ud-Din

“…Sustainable access to affordable medicines remains a public health issue globally, including for high-income countries. To foster the debate on avenues for the…”
Get full text

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries by LEAPALD, Christine, MANTEL-TEEUWISSE, Aukje K, VOGLER, Sabine, VALKOVA, Silvia, DE JONCHEERE, Kees, LEUFKENS, Hubert G. M, WAGNER, Anita K, ROSS-DEGNAN, Dennis, LAING, Richard

“…To identify pharmaceutical policy changes during the economic recession in eight European countries and to determine whether policy measures resulted in lower…”
Get full text

Price and reimbursement for orphan medicines and managed entry agreements: does Italy need a framework? by Jommi, Claudio, Addis, Antonio, Martini, Nello, Nicod, Elena, Pani, Marcello, Scopinaro, Annalisa, Vogler, Sabine

“…This article illustrates a consensus opinion of an expert panel on the need and usefulness of a framework for price and reimbursement (P&R) process and managed…”
Get full text

Pharmaceutical regulation and policies in Austria by VOGLER, Sabine

“…Austria is a middle-sized, high-income country in Central Europe with universal health coverage and a highly fragmented health care system. Medicines for…”
Get full text

Tackling medicine shortages during and after the COVID-19 pandemic: Compilation of governmental policy measures and developments in 38 countries by Vogler, Sabine

“…•High-income countries apply a set of policy measures to address medicine shortages.•The growth in medicine shortages has prompted additional measures.•Earlier…”
Get full text

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference by Vogler, Sabine, Zimmermann, Nina, Babar, Zaheer-Ud-Din, Busse, Reinhard, Espin, Jaime, Mantel-Teeuwisse, Aukje K, Panteli, Dimitra, Suleman, Fatima, Wirtz, Veronika J

“…The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience…”
Get full text

Impact of discounts on medicine prices by Schneider, Peter, Vogler, Sabine

Get full text